Ask a Question

User freontiger16

Member for: 1 year (since Nov 22, 2023)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/LY2228820.html
About: Days gained reply discriminates treatment response inside people along with frequent glioblastoma acquiring bevacizumab-based therapies.

Activity by freontiger16

Score: 100 points (ranked #162)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for freontiger16

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...